Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
Clinical trial NCT02504892 · TERMINATED
Trial details
- NCT number
- NCT02504892
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-21
- Primary completion
- 2018-04-17
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.